Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

  1. Dimopoulos, M.A.
  2. Stewart, A.K.
  3. Masszi, T.
  4. Špička, I.
  5. Oriol, A.
  6. Hájek, R.
  7. Rosiñol, L.
  8. Siegel, D.
  9. Mihaylov, G.G.
  10. Goranova-Marinova, V.
  11. Rajnics, P.
  12. Suvorov, A.
  13. Niesvizky, R.
  14. Jakubowiak, A.
  15. San-Miguel, J.
  16. Ludwig, H.
  17. Palumbo, A.
  18. Obreja, M.
  19. Aggarwal, S.
  20. Moreau, P.
Revue:
British Journal of Haematology

ISSN: 1365-2141,  0007-1048

Année de publication: 2017

Volumen: 177

Número: 3

Pages: 404-413

Type: Article

DOI: 10.1111/BJH.14549 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus